4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-048641
Director sold 4,730 shares at $26.91 ($127,284)
- Director acquired 4,096 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Welgus Howard G. Director | 2026-07-15 | Option exercise 10b5-1 | +822 | $6.52 | $5,361 | 38,565 | D: show line 1 in the form |
| Welgus Howard G. Director | 2026-07-15 | Option exercise 10b5-1 | +1,019 | $7.51 | $7,653 | 39,584 | D: show line 2 in the form |
| Welgus Howard G. Director | 2026-07-15 | Option exercise 10b5-1 | +2,255 | $8.63 | $19,461 | 41,839 | D: show line 3 in the form |
| Welgus Howard G. Director | 2026-07-15 | Sale 10b5-1 | −4,730 | $26.91 | $127,284 | 37,109 | D: show line 4 in the form |
| Open-market sales · 4,730 sh · avg $26.91 · $127,284 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Welgus Howard G. Director | 2026-07-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −822 | 8,218 | D: show line 5 in the form | |||||
| Welgus Howard G. Director | 2026-07-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,019 | 10,182 | D: show line 6 in the form | |||||
| Welgus Howard G. Director | 2026-07-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,255 | 22,542 | D: show line 7 in the form |
Loading xslF345X06/wk-form4_1784318483.xml…